Woodline Partners’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$50.4M Sell
660,525
-122,584
-16% -$8.84M 0.19% 137
2025
Q4
$50M Buy
783,109
+461,667
+144% +$28.5M 0.19% 131
2025
Q3
$20.3M Buy
321,442
+59,116
+23% +$4.13M 0.1% 281
2025
Q2
$19.6M Buy
262,326
+252,596
+2,596% +$19.8M 0.1% 293
2025
Q1
$857K Buy
9,730
+2,769
+40% +$261K 0.01% 779
2024
Q4
$636K Buy
+6,961
New +$714K ﹤0.01% 811

Other funds holding EMN

Woodline Partners's EMN Position: Q1 2026 in Review

Woodline Partners reduced its Eastman Chemical (EMN) stake by 16% in Q1 2026, selling an estimated $8.84M and leaving 660,525 shares worth $50.4M. The position accounts for 0.19% of the portfolio, ranked #137.

Woodline Partners first reported a position in EMN in Q4 2024 and has held it in 6 quarters since. 634 funds tracked by Wall St. Rank hold EMN as of Q1 2026.

  • Woodline Partners held 660,525 shares of Eastman Chemical worth $50.4M as of Q1 2026.
  • Woodline Partners sold 122,584 Eastman Chemical shares in Q1 2026, an estimated $8.84M.
  • Eastman Chemical made up 0.19% of Woodline Partners's portfolio in Q1 2026, its #137 holding.
  • Woodline Partners first reported a position in Eastman Chemical in Q4 2024 and has held it in 6 quarters since.
  • 634 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.